Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Insulin Resistance
- Sponsor
- University of Texas, El Paso
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- Glycemic Control
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance training combined with NMES (RT +NMES), or resistance training (RT) group (n=20 per group), followed by collection of post-intervention data. The control group will receive electrical stimulation up to sensory level, the NMES group will receive stimulation up to tolerable intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to tolerable intensity during resistance training, and the RT group will only receive exercise training. Control and NMES group will self administer stimulation at home. Pre-and post-intervention data includes measurements for body composition, resting metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.
Investigators
Sudip Bajpeyi
Professor
University of Texas, El Paso
Eligibility Criteria
Inclusion Criteria
- •Overweight/Obese (BMI ≥25)
- •Sedentary Lifestyle: Physical Activity Level\<1.4
- •Less than 150min/week of structured Exercise
Exclusion Criteria
- •Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications
- •Excessive alcohol, drug abuse, smoking
- •Pregnant Women
- •Unwilling to adhere to the study Intervention
Outcomes
Primary Outcomes
Glycemic Control
Time Frame: 8 weeks
Insulin Sensitivity will be measured through repeated blood sampling during an Oral Glucose Tolerance Test and Continuous Glucose Monitoring
Secondary Outcomes
- Amount of lean mass(8 weeks)
- Respiratory Exchange Ratio(8 Weeks)